German prospective register study for detecting the treatment of gynecological sarcomas in clinical routine

German prospective register study for detecting the treatment of gynecological sarcomas in clinical routine - REGSA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009240

Enrollment

1200

Registered

2015-08-18

Start date

2015-10-02

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leimyosarcom endometrial stromal sarcoma undifferenciated endometrial stroma sarcom C49 C54

Interventions

Group 1: documentation of the current treatment of gynaecological sarcoma and their treatment success after 12 month regardless of type of therapy and line of therapy

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. patients with gynecological sarcomas regardless of therapy and treatment line, 2. Informed Consent, 3. age > 18 ys.

Exclusion criteria

Exclusion criteria: 1. Patients with non-gynecologic sarcomas 2. Lack of informed consent

Design outcomes

Primary

Measure	Time frame
1. Complete detection of gynecological sarcomas in Germany 2. Registration and safeguarding of diagnostic and therapeutic standards at different subtypes	—

Secondary

Measure	Time frame
1. Basis for innovative new therapeutic concepts	—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactJasmin Yamamoto

NOGGO e.V.

jasmin.yamamoto@noggo.de030403686532

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026